Finance

Beta
Lists
4592:TYO
SanBio Co Ltd
¥1,022.00
-7.34%
(-81.00) 1D
Jun 19, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4592...
Open
¥1,088
High
¥1,105
Low
¥1,012
Mkt. cap
79.78B
Avg. vol.
1.83M
Volume
1.28M
52-wk high
¥3,990
52-wk low
¥1,012
EPS
-¥42
Shares outstanding
49.72M
No. of employees
33
Open
¥1,088
High
¥1,105
Low
¥1,012
Mkt. cap
79.78B
Avg. vol.
1.83M
Volume
1.28M
52-wk high
¥3,990
52-wk low
¥1,012
EPS
-¥42
Shares outstanding
49.72M
No. of employees
33
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to 4592 in the past 3 months
Hold
Buy
0
Hold
4
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for 4592 in the last 3 months.
Highest
Current ¥1,022.00
¥2,200.00 (+115.26%)
Average
¥1,574.45 (+54.06%)
Lowest
¥1,200.00 (+17.42%)
News stories
From sources across the web
About SanBio Co Ltd
CEO-
Employees33
FoundedFeb 2001
Headquarters-
SectorBiotechnology
Websitesanbio.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
622.86M
573.34M
757.89M
680.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
257.79M
212.51M
362.14M
272.58M
Operating expense
880.65M
785.85M
1.12B
953.34M
Total operating expenses
880.65M
785.85M
1.12B
953.34M
Operating income
-880.65M
-785.85M
-1.12B
-953.34M
Other non operating income
-34.74M
-5.62M
-75.43M
-5.47M
EBT including unusual items
-730.72M
-677.57M
-1.13B
-778.31M
EBT excluding unusual items
-730.72M
-677.57M
-1.13B
-779.79M
Income tax expense
-265.21M
39.08M
-3.34M
57.73M
Effective tax rate
36.29%
-5.77%
0.29%
-7.42%
Other operating expenses
-
-
-
-
Net income
-465.51M
-716.64M
-1.13B
-836.04M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
399.00K
571.00K
3.78M
10.80M
Interest expense
-9.71M
-9.40M
-9.56M
-8.83M
Net interest expenses
-9.31M
-8.83M
-5.78M
1.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
-879.15M
-783.50M
-1.12B
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer